Giuseppe Di Pasquale

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 855 citations · Full text

Thrombosis, Cardiovascular Disease, Stroke +13

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial

Shamir R. Mehta, Jean‐François Tanguay, John W. Eikelboom et al. · The Lancet · 2010 · 824 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +14

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 749 citations · Full text

Thrombosis, Cardiovascular Disease, Atherosclerosis +12

Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial

Hans‐Christoph Diener, Stuart J. Connolly, Michael D. Ezekowitz et al. · The Lancet Neurology · 2010 · 451 citations

Thrombosis, Venous Thrombosis, Cardiovascular Disease +11

The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study

Stuart J. Connolly, Lars Wallentin, Michael D. Ezekowitz et al. · Circulation · 2013 · 218 citations